VELA-1 and VELA-2 are two identical trials to evaluate the efficacy and safety of sonelokimab in adult participants with moderate to severe hidradenitis suppurativa (HS) and the first Phase 3 program ...
Background Patients with hypertrophic cardiomyopathy (HCM) often reduce their physical activity due to concerns about sudden ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback